Álvaro J. Obaya - Concepedia

Author

Álvaro J. Obaya

Also Known As

A J Obaya, A OBAYA, A. Obaya, A.J. Obaya, ALVARO J. OBAYA, Alvaro J Obaya, Alvaro J. Obaya, Alvaro J. Obaya (452017), Alvaro Jesus Obaya, Alvaro Obaya

Publications

Citations

H-Index

Concepts

All Affiliations

Universidad de Oviedo Instituto de Investigación Sanitaria del Principado de Asturias Hospital Universitario Central de Asturias Brown University Institut d'Investigació Biomédica de Bellvitge

ÁJ

About

Álvaro J. Obaya is an author at Universidad de Oviedo specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	1.4K
2	Engineering	4	4	163
3	Natural Sciences	4	4	411
4	Biomedical Engineering	3	3	94
5	Biochemistry	2	2	47

Álvaro J. Obaya

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Identification of <i>CDK4</i> as a target of c-MYC Heiko Hermeking, Carlo Rago, Marino Schuhmacher, Proceedings of the National Academy of Sciences	2000	475
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Maria K. Mateyak, Álvaro J. Obaya, Susumu Adachi, PubMed C-myc Null CellsImmunologyPathologyCell ProliferationCell Cycle	1997	447
c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points Maria K. Mateyak, Álvaro J. Obaya, John M. Sedivy Molecular and Cellular Biology	1999	334
Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains Santiago Cal, Álvaro J. Obaya, Cecilia Garabaya, Gene Expression AnalysisProtein FunctionProtein ExpressionNatural SciencesMetalloprotein	2002	273
c-<i>myc</i> null cells misregulate <i>cad</i> and <i>gadd45</i> but not other proposed c-Myc targets Andrew B. G. Bush, Maria K. Mateyak, Kerri A Dugan, Genes & Development	1998	175
Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis Mehdi El Hour, Ángela Moncada-Pazos, Silvia Blacher, Oncogene Tumor BiologyDevelopmental BiologyAngiogenesisAdamts12-deficient MiceMedicine	2010	112
Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors Rocío G. Urdinguio, Agustín F. Fernández, Ángela Moncada-Pazos, Cancer Research Independent Antitumor ActivityImmunologyPathologyImmunotherapyCancer Biology	2012	92
Cell–cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas Miriam Fanjul‐Fernández, Vı́ctor Quesada, Rubén Cabanillas, Nature Communications Tumor BiologyTumour SuppressorsMedicineCancer Cell BiologyLaryngeal Carcinomas	2013	91
The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway Maria Llamazares Prada, Álvaro J. Obaya, Ángela Moncada-Pazos, Journal of Cell Science ImmunologyRecombinant Human Adamts12Cancer BiologyTumor BiologyAngiogenesis	2007	91
The Proto-oncogene c-myc Acts through the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1to Facilitate the Activation of Cdk4/6 and Early G1Phase Progression Álvaro J. Obaya, Iulia Kotenko, Michael D. Cole, Journal of Biological Chemistry	2002	86

Page 1